Benchmarks ended Monday’s trading session in the red as investors feared a stronger dollar and weaker oil prices may affect first quarter earnings results. Investors were also apprehensive about the timing of the Federal Reserve’s decision to hike federal funds rates.For a look at the issues currently facing the markets, make sure to read today’s Ahead of Wall Street articleThe […]
Benchmarks ended Wednesday’s volatile trading session with modest gains after Fed minutes hinted at a possible rate hike this year. While “several” officials favored a rate hike in June, others opined a rate hike isn’t necessary until later this year as strong dollar and drop in oil prices will keep inflation rate lower. Meanwhile, new deal between Mylan and Perrigo […]
Benchmarks posted solid gains on Monday after weak jobs report raised hopes of a delay in interest rate hike. Friday’s nonfarm payroll data showed job additions slumped to a 15-month low in March. Meanwhile, U.S. service sector growth rate also touched a three-month low last month.For a look at the issues currently facing the markets, make sure to read today’s […]
Momentum Stocks: Caution Ahead (Part 4 of 6)(Continued from Part 3)Another case in point is biotech.Biotech is another obvious example of the momentum trade. It is a high “beta” or risky industry that has been a strong relative performer for many years. Through the close of the week ended March 20, the Nasdaq Biotech Index had surged 20% year-to-date. The following […]
China central bank governor’s indications about additional monetary stimulus and a slew of new deals in the healthcare sector helped benchmarks start the holiday shortened week on a positive note. China’s move to ease lending requirements for buying a second home also added to the bullish sentiment. While all 10 sectors of the S&P 500 ended in the green, 28 […]
Benchmarks ended the last trading session of the week on a positive note after Fed Chair Janet Yellen said there was a possibility of a gradual hike in interest rates sometime this year. The Nasdaq was boosted by a possible deal between Intel and Altera. Gains in bio-tech stocks also helped the Nasdaq end in positive territory. However, benchmarks reported […]
Related CELGIs It Closing Time At The Biotech Bar?Weekly Options Outlook: Bulls Leave Money On The Table Despite A Week-End WinCelgene backs away from development of mAb for blood cancer(Seeking Alpha)Related ILMNIs It Closing Time At The Biotech Bar?3 Niche ETFs Breaking Out3 Excellent Biotech Stocks to Buy on the Dip – Stocks in the News(Zacks)By and large, the short […]
View photo.By and large, the short interest moves in the leading biotechs and emerging pharmaceuticals were mild between the February 27 and March 13 settlement dates. However, Celgene Corporation (NASDAQ: CELG), Illumina, Inc. (NASDAQ: ILMN) and Medivation Inc (NASDAQ: MDVN) saw double-digit percentage upswings in their short interest.Here we take a quick look at how these three stocks have fared […]
Slump in biotech and technology stocks sent benchmarks to negative territory for third straight sessions on Wednesday. These sectors witnessed intense selling pressure as investors remained concerned that strength in the U.S. dollar will negatively impact earnings growth in upcoming quarters. However, the dollar weakened yesterday against major currencies following release of dismal durable orders data. The Nasdaq witnessed its […]
After an incredible run, investors are finally seeing some pain in the biotech and broader health care sector. Major biotechnology indexes were off over 4% in Wednesday trading, while the short term trend has not been favorable either.Some investors may now think that the bubble has burst for the high growth biotech sector, but there are actually still a few […]
